News | October 17, 2007

Guerbet Highlights X-Ray Agent, Oxilan

October 18, 2007 - Guerbet will feature at TCT 2007 its x-ray contrast agent, Oxilan (ioxilan) injection, a contrast agent that is a non-ionic low-viscous and low-osmolar monomer.

It Oxilan has reportedly had favorable results with usage feedback regarding side-effects, and Guerbet’s products compete in the x-ray contrast media market, a market where accurate diagnosis is of utmost importance. Although opacification is a major metric used to judge the quality of contrast media, other significant characteristics such as ionicity, chemical structure, osmolality, and viscosity have important influences on their efficacy and safety. Guerbet has emphasized the point that these additional characteristics can significantly effect visualization, hemodynamics, thrombogenecity, contrast-induced nephropathy, and other various clinical outcomes. This emphasis has been implemented in the development of Oxilan, whose chemical characteristics have resulted in high quality imaging with minimal side effects.
Peak plasma levels occur immediately following intravenous injection, allowing imaging to occur rapidly and Guerbet recognized these clinical benefits of non-ionic monomers. Oxilan was developed in this category with its unique chemical structure to ensure high quality.

For more information: www.guerbet.com

Related Content

ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media| July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Osprey Avert
News | Cath Lab| May 13, 2016
May 13, 2016 — In the largest study of its kind, a new device has been found to significantly reduce the volume of ra
GlobalData, contrast media injectors market,
News | Contrast Media Injectors| May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors| October 01, 2015
Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline Catheter with MST...
Technology | March 06, 2015
Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an...
Contrast media injectors. angiography contrast injectors

The Bayer Arterion contrast injector.

Feature | Contrast Media Injectors| February 10, 2015 | Raissa Rocha and Dave Fornell
There have been several recent advances with contrast media injector technology, including cutting costs by reducing...
Technology | December 23, 2014
Bayer unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America (...
Technology | November 24, 2014
Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a...
Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray
Feature | March 11, 2014
Guerbet announced a worldwide launch of FlowSens, a ...
Overlay Init